IL6 and COVID-19: Twenty-one patients with severe COVID-19 received tocilizumab and showed improvement in fever, respiratory and imaging parameters.55 After infusion of tocilizumab IL-6 levels tend to rise and then to fall,56 individuals who do not experience a drop in IL-6 levels may have a worse outcome.